Navigation Links
Vanderbilt scientists report first effective medical therapy for rare stomach disorder
Date:11/25/2009

A drug used to treat colorectal cancer also can reverse a rare stomach disorder and should be considered first-line therapy for the disease, researchers at Vanderbilt University Medical Center report this week.

Mntrier's disease causes thickening of the stomach lining, severe abdominal pain, nausea and vomiting, as well as anemia and swelling in the feet and ankles due to protein loss. Patients are at increased risk for gastric cancer. Previously, the only effective treatment was gastrectomy surgical removal of the stomach.

The targeted cancer drug cetuximab, brand name Erbitux, relieved symptoms of severe Mntrier's disease in seven patients who completed a one-month course of treatment. Four of them showed near-complete remission, the Vanderbilt researchers report in the Nov. 25 issue of the journal Science Translational Medicine.

"We have identified the first effective medical therapy for this disorder," said Robert Coffey, M.D., Ingram Professor of Cancer Research and the paper's senior author.

Erbitux is a monoclonal antibody that blocks the binding of transforming growth factor-alpha, or TGF-alpha, a signaling protein, to the epidermal growth factor (EGF) receptor. Patients with Mntrier's disease have abnormally high levels of TGF-alpha.

In studies dating back 20 years, Coffey and his colleagues found that TGF-alpha causes proliferation of the stomach lining and stimulates mucous production while suppressing acid secretion. Transgenic mice that over-express TGF-alpha in the stomach exhibit all of the hallmarks of Mntrier's disease.

The current study involved nine patients who were considering gastrectomy. Two patients dropped out of the study, but the rest experienced significant relief of symptoms within hours or days after beginning treatment. All seven continued taking the drug after the monthlong study ended.

Of the four patients who experienced near-complete remission of the disease, one of
'/>"/>

Contact: Bill Snyder
william.snyder@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Ovarian Cancer Coalition Partners With Consuelo Vanderbilt Costin
2. Vanderbilt Experts For Health Care Debate
3. Vanderbilt joins national consortium to develop new cancer therapies
4. Vanderbilt researchers pioneer an advanced sepsis detection and management system
5. NIH-funded Vanderbilt Research Seeks Ways to Avoid Information Overload in Health Care Choices Among Seniors
6. Vanderbilt University Medical Center and Waters Collaborate on Tissue Imaging Research Using SYNAPT HDMS
7. Vanderbilt Medical Center chosen as Evidence-based Practice Center
8. Vanderbilt nets brain gene research center
9. Childrens Hospital Oakland scientists discover soy component may be key to fighting colon cancer
10. BIDMC scientists awarded grants from Michael J. Fox Foundation for Parkinsons research
11. Scientists find molecular trigger that helps prevent aging and disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Michigan are pleased to announce an agreement to publish ... Endocrinology , which is now open for submissions and ... , The journal is led by Editor-in-Chief, Meng ... Metabolism, Endocrinology, and Diabetes, at the University of Michigan, ... international Editorial Board. , Clinical Diabetes and ...
(Date:9/30/2014)... cells cannot multiply and cardiac muscles contain few ... itself after a heart attack. Now Tel Aviv ... standard in cardiac tissue engineering. , Dr. Tal ... TAU,s Department of Biotechnology, Department of Materials Science ... have been developing sophisticated micro- and nanotechnological tools ...
(Date:9/30/2014)... NY Four scientists at Cold Spring Harbor Laboratory ... under two new CSHL grants announced in Washington today. ... by the National Institutes of Health (NIH), totaling $46 ... initial funding for the BRAIN Initiative. ... was launched by the President in the spring of ...
(Date:9/30/2014)... A new report launched today by the ... Study on Ageing) conducted by academics from the ... Ireland, has highlighted the serious, complex and unique ... population. , The IDS-TILDA study is the first ... only one in the world with the ability ...
(Date:9/30/2014)... SIMpalm, the top iPhone app development ... great social networking music sharing experience. Lyricz LLC officially ... and iPod touch®. The App allows users to take ... pre-populated ITunes account. This app also gives users the ... photo of their choice to the snippet of selected ...
Breaking Medicine News(10 mins):Health News:BioMed Central to publish open access journal in collaboration with the University of Michigan 2Health News:A heartbeat away? Hybrid 'patch' could replace transplants 2Health News:4 Cold Spring Harbor Laboratory scientists will contribute to President Obama's BRAIN Initiative under new NIH grants 2Health News:4 Cold Spring Harbor Laboratory scientists will contribute to President Obama's BRAIN Initiative under new NIH grants 3Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 2Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 3Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 4Health News:LYRICZ App for iPhone®, Helps You Share Images with Music to Inspire and Influence 2
... chronically ill Medicaid patients designed to provide care ... Jan. 27 Chronically ill members ... Health Insurance plans (CHIP) in Philadelphia are now ... homes, thanks to an innovative new partnership with ...
... A study by healthcare market research firm Manhattan Research ... support for continuing medical education (CME) funding. The results ... in the medical community about the role of commercial ... positions of those who actually use continuing medical education, ...
... thinner, Munro & Associates steps up for their customersTROY, ... and great for our customers," says Sandy Munro, Founder ... deliver 21 years worth of experience more efficiently and ... in today,s climate could spell disaster. No company can ...
... in fruit flies has led researchers to a sensitive and ... common type of kidney cancer. In the journal Science ... the University of Chicago shows that the biomarker known as ... cell carcinomas but not by normal kidney tissue. , Physicians ...
... state, construct prison health care centers throughout California.LOS ANGELES, ... this week to prevent a federal judge and his ... treasury for the sole purpose of reconstructing the state,s ... opposes the proposal to construct seven new prison facilities, ...
... Ages Two Years and Older , FT. WASHINGTON, Pa., ... Inc., today announced the availability of Children,s ZYRTEC(R) Allergy ... flavor product used to treat perennial and seasonal allergic ... ages two years and older. Children,s ZYRTEC(R) Allergy ...
Cached Medicine News:Health News:Physician Home Visits Centerpiece of New AmeriChoice and INSPIRIS Partnership in Philadelphia 2Health News:Physician Home Visits Centerpiece of New AmeriChoice and INSPIRIS Partnership in Philadelphia 3Health News:Manhattan Research Survey Finds That Physicians Overwhelmingly Support Commercially-Funded Continuing Medical Education 2Health News:Manhattan Research Survey Finds That Physicians Overwhelmingly Support Commercially-Funded Continuing Medical Education 3Health News:Survival Favors the Prepared 2Health News:Roadkill study could speed detection of kidney cancer 2Health News:Ventura County Taxpayers' Group Files Suit to Stop State-of-the-Art Hospitals for Incarcerated Felons 2Health News:Children's Sugar-Free, Dye-Free ZYRTEC(R) Allergy Syrup Now Available 2Health News:Children's Sugar-Free, Dye-Free ZYRTEC(R) Allergy Syrup Now Available 3
(Date:9/30/2014)... 30, 2014 Summary This report ... pharmaceutical companies regarding their Information & Communications Technology ... companies currently allocate their ICT budgets across the ... IT services, communications, and consulting. Key ... companies highlights that X% of respondents anticipate an ...
(Date:9/30/2014)... Investor-Edge has initiated coverage on the following ... Zentaris Inc. (NASDAQ: AEZS ), OPKO Health ... (NYSE MKT: NAVB), and Exact Sciences Corporation (NASDAQ: EXAS). ... at: http://investor-edge.com/register . On Monday, September ... 0.14%, the Dow Jones Industrial Average finished the day ...
(Date:9/30/2014)... 2014  Come fall, many children, teenagers, and even ... want to be for Halloween. And, a number of ... contact lenses bought without a prescription. Halloween, ... purchase and wear contact lenses without a prescription. According ... consumer survey, 17 percent of Americans have worn ...
Breaking Medicine Technology:ICT investment trends in pharmaceuticals - Enterprise ICT spending patterns through to the end of 2015 2ICT investment trends in pharmaceuticals - Enterprise ICT spending patterns through to the end of 2015 3Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 2Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 3Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 4Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 5The Spooky Truth: What You Need To Know About Contact Lens Hygiene 2The Spooky Truth: What You Need To Know About Contact Lens Hygiene 3
... Quantros, a leading software and services provider for ... with Det Norske Veritas Healthcare, Inc. (DNV). DNV ... Medicare and Medicaid Services (CMS) as an authorized ... accreditation standards into the Quantros ACE(TM) software application. ...
... N.Y., Nov. 13 Misonix, Inc. (Nasdaq: MSON ... technology, which in Europe is used for the ablation ... has entered into a new, three year distribution agreement ... distribution of the SonaStar(TM) Ultrasonic Surgical Aspirator, the BoneScalpel(TM) ...
Cached Medicine Technology:Quantros Announces Partnership With Hospital Accreditation Agency DNV 2Misonix Announces New Distribution Agreement For The United Arab Emirates (UAE) 2Misonix Announces New Distribution Agreement For The United Arab Emirates (UAE) 3
The Spex SkinSkan is the only in-vivo, fibre-optic spectrofluorometer designed specifically for skin-fluorescence measurements. It is also ideal for many remote sensing steady-state fluorescence appl...
The unique RF-1501 optical design provides exceptional sensitivity in an incredibly compact instrument....
... Quantitation of DNA, RNA, Or Fluorescent Tags. Accurate ... is critical to life science research. The RF-Mini ... measure quantities as small as 1ng/ml of DNA ... of excitation and emission filters, the RF-Mini 150 ...
The Fluoroskan Ascent FL is equipped with both fluorometric and luminometric measurement technologies, providing a full coverage for fluorometric, glow and flash luminometric applications even in the...
Medicine Products: